Hydroxychloroquine
-
Stop prescribing hydroxychloroquine for Covid-19, warn researchers
Health | Aug 31, 2021, 11:20 PM ISTHydroxychloroquine approved to treat or prevent malaria as well as some auto-immune conditions -- does not help in the recovery of patients hospitalised due to Covid-19, but may cause harm.
-
Remdesivir, HCQ have no antiviral effects: WHO study
World | Jul 13, 2021, 06:52 PM ISTNeither Remdesivir, nor hydroxychloroquine (HCQ) helps in recovery of patients hospitalised due to Covid-19, according to a new study conducted by the World Health Organization (WHO).
-
Patients in many countries report HCQ shortages due to Covid-19
World | Nov 07, 2020, 04:45 PM ISTPatients with rheumatic diseases across Africa, Southeast Asia, the Americas and Europe had trouble filling their prescriptions of hydroxychloroquine, during the 2020 global coronavirus pandemic, when antimalarials were touted as a possible Covid-19 treatment, says a new study.
-
Study finds hydroxychloroquine plus azithromycin increases heart risk
Lifestyle | Aug 30, 2020, 10:47 AM ISTThe largest safety study performed on both HCQ and HCQ+AZM suggests that the combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks, including mortality.
-
Hydroxychloroquine-azithromycin combination increases heart attack risk: Lancet
Health | Aug 26, 2020, 05:26 PM ISTAccording to the study, HCQ+AZM had a cardiovascular mortality risk that was more than twice (2.19) as high as the comparative treatment even in the short-term based on findings from more than 3,20,000 users of that combination therapy.
-
HCQ ineffective as preventive antiviral against Covid-19: Study
World | Aug 18, 2020, 11:58 AM ISTMany researchers have focused on patients with systemic lupus erythematosus (SLE) and RA because HCQ is frequently taken by these patients. Anecdotal reports in the early stages of the pandemic showed these patients were not getting Covid-19.
-
New drug RLF-100 shows dramatic results for critical COVID-19 patients
Good News | Aug 06, 2020, 08:44 AM ISTDoctors at a hospital here have used a new drug called RLF-100, also known as aviptadil, that has led to rapid recovery from respiratory failure in critically ill COVID-19 patients. The drug has been approved by the FDA for emergency use at multiple clinical sites in patients who are too ill to enter the FDA's Phase 2/3 trials.
-
Trump defends use of hydroxychloroquine, says it works in early stages of COVID-19 infection
World | Jul 29, 2020, 11:42 AM ISTUS President Donald Trump has again defended the use of hydroxychloroquine to ward off coronavirus, saying many frontline medical workers agree with him that the malaria drug works in the early stages of COVID-19 infection, despite mounting evidence that it is ineffective in treating the disease.
-
HCQ, chloroquine do not show antiviral effect against coronavirus, studies reveal
World | Jul 22, 2020, 05:16 PM ISTHydroxychloroquine (HCQ) and chloroquine, two drugs, commonly used for the treatment of malaria, have been investigated for their potential to treat COVID-19 in more than 80 registered clinical trials, and have been shown to inhibit the novel coronavirus, SARS-COV-2 infection in cell cultures, the scientists said.
-
Hydroxychloroquine has become highly politicised in US but India uses it widely: White House
World | Jul 08, 2020, 08:29 AM ISTThe use of hydroxychloroquine to treat coronavirus patients has become highly politicized in the US but it is used widely in India, a top White House official has said, asserting the latest research showed the malaria drug is highly effective in early stages of COVID-19.
-
WHO halts trial of HCQ, lopinavir/ritonavir after 'lack of evidence' in hospitalised patients
World | Jul 05, 2020, 04:17 PM ISTThe World Health Organization has discontinued trials of the combination HIV drugs lopinavir and ritonavir as a combined treatment for hospitalized coronavirus patients after interim results showed the drugs “produce little or no reduction in the mortality” of COVID-19 patients.
-
Novartis discontinues hydroxychloroquine trial over enrollment challenges
World | Jun 20, 2020, 07:29 PM ISTSwiss drugmaker Novartis has announced to discontinue Hydroxychloroquine (HCQ) clinical trial over acute enrollment challenges that have made completion of the trial infeasible, and not because any safety issues were reported or efficacy conclusions made.
-
Export ban on anti-malarial drug hydroxychloroquine lifted with immediate effect
India | Jun 18, 2020, 09:56 PM ISTThe government on March 25 had banned the export of the drug, which was touted as a promising medicine in the treatment of COVID-19 pandemic.
-
Doctors can still prescribe HCQ to patients, says US health Secretary
World | Jun 16, 2020, 09:30 AM ISTDoctors can still prescribe anti-malarial drug hydroxychloroquine to patients, US Health Secretary Alex Azar said, hours after the FDA withdrew the emergency use authorisation of chloroquine and HCQ in the treatment of COVID 19 patients.
-
US drug body FDA revokes Hydroxychloroquine status as emergency medicine to treat COVID-19
World | Jun 15, 2020, 11:33 PM ISTThe FDA said it was no longer reasonable to believe that oral formulations of hydroxychloroquine and the related drug chloroquine may be effective in treating the respiratory illness caused by the novel coronavirus.
-
Health ministry recommends remdesivir for moderate cases, HCQ for early course of COVID-19
India | Jun 13, 2020, 07:28 PM ISTThe Health Ministry on Saturday recommended the use of antiviral drug remdesivir in a moderate stage of COVID-19 while backtracking from its earlier stance on hydroxychloroquine, saying the anti-malarial drug should be used in the early course of the disease and not on critically ill patients.
-
No survival benefit of treating COVID-19 patients with HCQ: Study
India | Jun 06, 2020, 07:22 PM ISTResearchers have found that the drug hydroxychloroquine — with or without the antibiotic azithromycin — did not reduce the risk of ventilation or death, and was associated with longer length of hospital stay in COVID-19 patients.
-
In first COVID-19 research scandal, Lancet retracts major hydroxychloroquine paper
World | Jun 05, 2020, 08:02 AM ISTJust as context, this development comes at a time when hydroxychloroquine has proved ineffective in the first large study which tests it in people in close contact with COVID19 infected people. These results were published this week by the New England Journal of Medicine.
-
WHO says anti-malaria drug hydroxychloroquine coronavirus trials to resume
World | Jun 03, 2020, 10:21 PM ISTThe World Health Organization on Wednesday said that clinical trials of the drug hydroxychloroquine will resume, having been suspended pending a safety review in the search for coronavirus treatments.
-
New study shows how hydroxychloroquine may cause heartbeat disturbances
Science | Jun 02, 2020, 11:11 AM ISTResearchers have used an optical mapping system to demonstrate how the malaria drug hydroxychloroquine, which has been promoted as a potential treatment for COVID-19, creates serious disturbances in the electrical signals that govern heartbeat.